SAREPTA THERAPEUTICS INC(NASDAQ:SRPT) stock News

SRPT Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Chartmill - Mentions: NAK CYCC STEM OPEN ...

Top stock movements in today's session.

2 days ago - By: Chartmill - Mentions: NAK CYCC LMFA CLSD ...

Friday's session: top gainers and losers

10 hours ago - By: The Rosen Law Firm PA

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRPT

12 hours ago - By: Bragar Eagel & Squire - Mentions: HIMS

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers and Sarepta and Encourages Investors to Contact the Firm

13 hours ago - By: Faruqi & Faruqi LLP

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics

2 days ago - By: Sarepta Therapeutics, Inc.

Sarepta Therapeutics Provides Statement on ELEVIDYS

2 days ago - By: DJS Law Group LLP

SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT

2 days ago - By: The Schall Law Firm

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

2 days ago - By: Benzinga - Mentions: TFC VOO DIA QQQ ...

Stocks Slip As Netflix Fails To Impress, Bitcoin Eyes Negative Week: What's Moving Markets Friday?

2 days ago - By: Bloomberg

FDA Is Investigating If Sarepta’s Gene Therapy Should Stay on Market

2 days ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT

3 days ago - By: Yahoo Finance

Sarepta (SRPT) Jumps Nearly 20% on Corporate Restructuring

3 days ago - By: Chartmill - Mentions: NAK XXII MESO CLSD ...

Gapping stocks in Friday's session

3 days ago - By: Investor's Business Daily - Mentions: MDT AAPL

Sarepta Therapeutics Crashes 26% After A Third Gene Therapy Patient Dies

3 days ago - By: Levi & Korsinsky, LLP

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sarepta Therapeutics, Inc.(SRPT) Shareholders

3 days ago - By: Chartmill - Mentions: NAK TLN MESO UAVS ...

Get insights into the top gainers and losers of Friday's pre-market session.

3 days ago - By: Schall Law

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

3 days ago - By: Robbins Geller Rudman & Dowd LLP

SRPT INVESTOR DEADLINE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

3 days ago - By: Bloomberg

Sarepta Says Another Patient Died After Receiving Gene Therapy

3 days ago - By: THE ROSEN LAW FIRM, P. A.

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit

3 days ago - By: The Rosen Law Firm PA

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRPT

4 days ago - By: Benzinga

Assessing Sarepta Therapeutics: Insights From 35 Financial Analysts

4 days ago - By: Chartmill - Mentions: GTI OPEN GAME XXII ...

What's going on in today's pre-market session

4 days ago - By: Chartmill - Mentions: GTI ACM GAME MXL ...

SAREPTA THERAPEUTICS INC (SRPT) Stock News

SRPT Latest News, Press Relases and Analysis

Top stock movements in today's session.

Friday's session: top gainers and losers

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRPT

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers and Sarepta and Encourages Investors to Contact the Firm

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics

Sarepta Therapeutics Provides Statement on ELEVIDYS

SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Stocks Slip As Netflix Fails To Impress, Bitcoin Eyes Negative Week: What's Moving Markets Friday?

FDA Is Investigating If Sarepta’s Gene Therapy Should Stay on Market

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT

Sarepta (SRPT) Jumps Nearly 20% on Corporate Restructuring

Gapping stocks in Friday's session

Sarepta Therapeutics Crashes 26% After A Third Gene Therapy Patient Dies

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sarepta Therapeutics, Inc.(SRPT) Shareholders

Get insights into the top gainers and losers of Friday's pre-market session.

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

SRPT INVESTOR DEADLINE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Sarepta Says Another Patient Died After Receiving Gene Therapy

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRPT

Assessing Sarepta Therapeutics: Insights From 35 Financial Analysts

What's going on in today's pre-market session

Get insights into the top gainers and losers of Wednesday's after-hours session.